Business & Industry
Gilead Secures GH31 Global Rights in $80M Oncology Deal
Gilead Sciences has added another synthetic lethal asset to its oncology portfolio, agreeing to pay $80 million upfront to obtain global rights to a...
Clinical Trials
AstraZeneca Breztri Reports Positive Phase III Trial Results
Results from the Phase III KALOS and LOGOS trials evaluating AstraZeneca Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF (320/28.8/9.6μg)) in patients with uncontrolled asthma have...
Business & Industry
Weight-Loss Pills Mark a Turning Point for Pharma Industry
The global pharmaceutical industry is entering a pivotal phase in obesity therapeutics as companies accelerate the transition from injectable GLP-1 drugs to oral weight-loss...
IT & Data Management
Quality Risk Management and the Role of Verified Drug Information
Effective quality risk management in pharmaceutical manufacturing hinges on the availability of verified drug information to ensure GMP compliance and product safety.
IT & Data Management
Improving Pharmacovigilance with Reliable Drug Interaction and Safety Data
Robust pharmacovigilance strategies rely on the continuous integration of high-quality drug interaction and safety data to protect patient health and ensure regulatory compliance.
IT & Data Management
The Strategic Value of Editorially Curated Drug Databases
While raw data is abundant, the strategic value of drug information lies in editorial curation, ensuring that every interaction, dosage, and safety alert is verified by experts.
IT & Data Management
The Evolving Role of Medical Information in the Digital Pharma Era
The transformation of medical information services into digital ecosystems has revolutionized how healthcare providers and patients access vital drug safety and efficacy data.
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
















